Data Suggest Sodium Oxybate Significantly Improves Pain And The Core Symptoms Of Fibromyalgia
Jazz Pharmaceuticals’ (Nasdaq: JAZZ) sodium oxybate (JZP-6) demonstrated statistically significant and clinically meaningful improvement in pain and the core symptoms associated with fibromyalgia, according to Phase III data presented last week at the 2009 Associated Professional Sleep Societies meeting in Seattle, WA. These data have not been evaluated by the FDA or other regulatory authorities for use of sodium oxybate in the treatment of fibromyalgia.
Related Posts
Tags: core, data, fibromyalgia, improves, oxybate, pain, significantly, sodium, suggest, symptoms
This entry was posted on Friday, June 19th, 2009 at 5:06 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



